ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 3 analysts with an average price target of $4.83. This is a potential upside of $0.47 (10.78%) from yesterday's end of day stock price of $4.36.

Adverum Biotechnologies's activity chart (see below) currently has 65 price targets and 68 ratings on display. The stock rating distribution of ADVM is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.79% with an average time for these price targets to be met of 472.04 days.

Highest price target for ADVM is $5.5, Lowest price target is $4, average price target is $4.83.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 17-Nov-2025.

Best performing analysts who are covering ADVM - Adverum Biotechnologies:

Tyler Van Buren Joshua Schimmer Joon Lee Gbola Amusa James Lee Luca Issi Dane Leone

Currently out of the existing stock ratings of ADVM, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Apr-2024

$5

$0.64 (14.68%)

10 months 14 days ago
(17-Nov-2025)

0/5 (0%)

$0.73 (17.10%)

Buy Since 28-Apr-2020

$5.5

$1.14 (26.15%)

$12

11 months 2 days ago
(29-Oct-2025)

2/10 (20%)

$1.27 (30.02%)

511

Hold Since 16-Apr-2025

$4

$-0.36 (-8.26%)

$5

11 months 3 days ago
(28-Oct-2025)

1/2 (50%)

$-0.26 (-6.10%)

168

Buy Since 18-Jul-2024

1 years 1 months 18 days ago
(13-Aug-2025)

1/3 (33.33%)

$30.52 (321.94%)

243

Hold Since 11-Nov-2022

$4

$-0.36 (-8.26%)

$5

1 years 4 months 16 days ago
(15-May-2025)

3/7 (42.86%)

$1.95 (95.12%)

321

Show more analysts

Please expand the browser size to see the chart

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 472 days for the stock forecasts to be reached, with an average price target met ratio of 43.79%.

Which analyst most recently updated their price target on ADVM (Adverum Biotechnologies)?

Matthew Caufield

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Matthew Caufield has 12 price targets and 9 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with the highest potential upside of $505.64

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Alethia Young with the lowest potential downside of -$3.16
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?